Testimonials
Don’t just take our word for it - see what some of our customers say about us.
REQUEST a quote
- Follow us on:
Don’t just take our word for it - see what some of our customers say about us.
"We perform gene editing in primary human immune cells for basic research, drug discovery, and to develop new cell therapies. Cergentis has helped us characterize the on- and off-target integrations when non-virally targeting new genetic material into human T cells with CRISPR, aiding our push towards clinical translation."
"Working with the team at Cergentis has allowed us to add an extra dimension to the analysis of our stable cell lines. Their understanding of our needs combined with the reliability and reproducibility of TLA analysis has resulted in a number of successful projects."
"TLA has become an indispensable tool to characterize transgene insertion events and complex gene targeting approaches."
"TLA analysis has proven to be very useful to quality control genetically engineered cell lines”
"TLA is a highly efficient method for mapping the insertion site of any transgene.”
"Cergentis quickly determined transgene insertion for three out of three lines along with providing information on deletions and rearrangements in chromosomal DNA at the site. The service was quick, accurate and reasonably priced, and reports were complete and helpful.”
"Thank you so much. Data about the structural changes in our patient are very clear. Really powerful technology!”
"We use TLA to sequence gene fusions and other rearrangements in genes of interest. We have been impressed by the quality of TLA and Cergentis' work and are testing the use of identified breakpoint sequences as targets for personalised minimal residual disease tests."
"Targeted Locus Amplification enables fast identification of new chromosomal rearrangements and genomic breakpoint sequences in human T-ALL and unraveled a higher complexity of chromosomal translocations of known T-ALL oncogenes as thus far appreciated.”
"Unknown translocation partners that drive expression of oncogenes as consequence of cryptic or previous unidentified chromosomal rearrangements were identified in T-cell leukemia patients using Targeted Locus Amplification.”
"TLA outperforms traditional methods used in CHO cell line characterisation and provides higher resolution and sensitivity.”
